Edition:
United States

People: United Therapeutics Corp (UTHR.OQ)

UTHR.OQ on NASDAQ Stock Exchange Global Select Market

122.27USD
4:00pm EDT
Change (% chg)

$-0.68 (-0.55%)
Prev Close
$122.95
Open
$123.94
Day's High
$124.33
Day's Low
$120.88
Volume
126,503
Avg. Vol
147,747
52-wk High
$152.55
52-wk Low
$100.64

Benkowitz, Michael 

Mr. Michael Benkowitz is President, Chief Operating Officer of the Company. He joined United Therapeutics in 2011 as Executive Vice President, Organizational Development. In this role, he was responsible for most companywide administrative functions, including human resources, information technology, corporate real estate and risk management, and was also responsible for many of our business development efforts and oversight of several of company key collaborations. He was promoted to President and Chief Operating Officer in June 2016, when he also became responsible for all of company commercial and medical affairs activities.

Basic Compensation

Total Annual Compensation, USD 733,333
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 10,085,400
Fiscal Year Total, USD 10,818,700

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Martine Rothblatt

35,535,000

Michael Benkowitz

10,818,700

Christopher Patusky

570,953

James Edgemond

8,075,900

Paul Mahon

12,215,200

Raymond Dwek

488,652
As Of  30 Dec 2017